Vaniqa (eflornithine)
- Region
- 🇪🇺 EU
- Active substance
- eflornithine
- Company
- Almirall, S.A.
- Status
- Authorised
- Therapeutic area
- Hirsutism
- EU approval
- Mon 19 Mar 2001
- Application
- EMEA/H/C/000325
- ATC
- D11AX
- Official record
- www.ema.europa.eu
Indication
Treatment of facial hirsutism in women.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Ifinwil Application withdrawn · Norgine B.V.
- 🇪🇺 Flynpovi Application withdrawn · Cancer Prevention Pharma (Ireland) Limited
Follow Vaniqa
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.